Su Hwan Kang

LBA2 Perioperative (periop) enfortumab vedotin (EV) plus pembrolizumab (pembro) in participants (pts) with muscle-invasive bladder cancer (MIBC) who are cisplatin-ineligible: The phase III KEYNOTE-905 study

Christof Vulsteke, H. Kaimakliotis, Pongwut Danchaivijitr et al. · Annals of Oncology · 2025 · 34 citations · Full text

Medicine, Oncology, Pharmacology +13

Correlation between 5-α reductase type 2 protein expression and methylation of 5-α reductase type 2 promotor gene of benign prostatic hyperplasia

Pil Moon Kang, Young Jin Kim, Won Tae Seo et al. · World Journal of Urology · 2018 · 16 citations

Medicine, Genetics, Molecular Biology +11

1365TiP A phase I/II, open-label study of BBT-176, a triple mutation targeting EGFR TKI, in patients with NSCLC who progressed after prior EGFR TKI therapy

S. Lim, Dongwook Kim, Jae-Eon Jung et al. · Annals of Oncology · 2021 · 13 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Changes in Renal Function After Laparoscopic Partial Nephrectomy: Comparison With Laparoscopic Radical Nephrectomy

Su Hwan Kang, Hyun Yul Rhew, Taek Sang Kim · Korean journal of urology · 2013 · 12 citations · Full text

Medicine, Perioperative Medicine, Surgery +17